Observe Medical Asa (OBSRV) - Total Assets
Based on the latest financial reports, Observe Medical Asa (OBSRV) holds total assets worth Nkr133.51 Million NOK (≈ $14.05 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Observe Medical Asa net assets for net asset value and shareholders' equity analysis.
Observe Medical Asa - Total Assets Trend (2016–2024)
This chart illustrates how Observe Medical Asa's total assets have evolved over time, based on quarterly financial data.
Observe Medical Asa - Asset Composition Analysis
Current Asset Composition (December 2024)
Observe Medical Asa's total assets of Nkr133.51 Million consist of 7.9% current assets and 92.1% non-current assets.
| Asset Category | Amount (NOK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr1.98 Million | 1.3% |
| Accounts Receivable | Nkr2.76 Million | 1.9% |
| Inventory | Nkr5.33 Million | 3.6% |
| Property, Plant & Equipment | Nkr228.00K | 0.2% |
| Intangible Assets | Nkr103.42 Million | 69.7% |
| Goodwill | Nkr33.07 Million | 22.3% |
Asset Composition Trend (2016–2024)
This chart illustrates how Observe Medical Asa's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Observe Medical Asa.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Observe Medical Asa's current assets represent 7.9% of total assets in 2024, a decrease from 16.1% in 2016.
- Cash Position: Cash and equivalents constituted 1.3% of total assets in 2024, down from 5.1% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 91.0% of total assets, an increase from 82.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 69.7% of total assets.
Observe Medical Asa Competitors by Total Assets
Key competitors of Observe Medical Asa based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Sino Medical Sciences Technology In
SHG:688108
|
China | CN¥1.34 Billion |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$127.41 Million |
|
Beijing Succeeder Technology Inc
SHG:688338
|
China | CN¥1.75 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.00 Billion |
|
Respiri Ltd
AU:RSH
|
Australia | AU$7.08 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €57.17 Million |
|
Atomo Diagnostics Ltd
AU:AT1
|
Australia | AU$9.48 Million |
Observe Medical Asa - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.18 | 0.25 | 0.70 |
| Quick Ratio | 0.12 | 0.19 | 0.20 |
| Cash Ratio | 0.00 | 0.02 | 0.00 |
| Working Capital | Nkr-55.30 Million | Nkr-83.58 Million | Nkr-2.49 Million |
Observe Medical Asa - Advanced Valuation Insights
This section examines the relationship between Observe Medical Asa's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 30.38 |
| Latest Market Cap to Assets Ratio | 0.11 |
| Asset Growth Rate (YoY) | -39.4% |
| Total Assets | Nkr148.41 Million |
| Market Capitalization | $16.19 Million USD |
Valuation Analysis
Below Book Valuation: The market values Observe Medical Asa's assets below their book value (0.11x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Observe Medical Asa's assets decreased by 39.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Observe Medical Asa (2016–2024)
The table below shows the annual total assets of Observe Medical Asa from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Nkr148.41 Million ≈ $15.62 Million |
-39.38% |
| 2023-12-31 | Nkr244.82 Million ≈ $25.76 Million |
+13.44% |
| 2022-12-31 | Nkr215.81 Million ≈ $22.71 Million |
+200.83% |
| 2021-12-31 | Nkr71.74 Million ≈ $7.55 Million |
-18.23% |
| 2020-12-31 | Nkr87.73 Million ≈ $9.23 Million |
+58.55% |
| 2019-12-31 | Nkr55.33 Million ≈ $5.82 Million |
-5.95% |
| 2018-12-31 | Nkr58.83 Million ≈ $6.19 Million |
-8.13% |
| 2017-12-31 | Nkr64.04 Million ≈ $6.74 Million |
-7.25% |
| 2016-12-31 | Nkr69.04 Million ≈ $7.26 Million |
-- |
About Observe Medical Asa
Observe Medical ASA develops and commercialize medical technology products for patients, healthcare professionals, and hospitals in Norway, Sweden, the United States, and rest of European countries. It offers Sippi, a digital and automated urine measurement system for urine monitoring and biofilm control; and Biim, a wireless pocketable ultrasound device for display of the ultrasound image and vi… Read more